aod9604 studies AOD-9604 AOD-9604 Vial — Lyophilized, HPLC

If a customer does not routinely monitor their email and would prefer a phone call, they must let us know when placing an order

Metabolic Pharmaceuticals terminated development for obesity in February 2007

AOD-9604 is a research peptide that has attracted significant scientific interest across the metabolic biology and adipose tissue research communities

O'Hollaren detailed the effective use of IV-infused NAD+ for the prevention, relief, or treatment of acute and chronic symptoms of addiction to a range of substances, including alcohol, heroin, opium extract, morphine, dihydromorphine, meperidine, codeine, cocaine, amphetamines, barbiturates, and tranquilizers (18)